Improved Automated Production of 18F-FMISO and Its Tumor Hypoxia Imaging by Micro-PET/CT
WANG Mingwei,ZHANG Yongping,ZHENG Yujia,BAO Xiao,ZHANG Yingjian
DOI: https://doi.org/10.11889/j.0253-3219.2013.hjs.36.100301
2013-01-01
Nuclear Techniques
Abstract:Background: 1-H-1-(3-[18F]fluoro-2-hydroxypropyl)-2-nitroimidazole(18F-FMISO) is a specific molecular imaging probe for tumor hypoxia imaging, and its PET/CT imaging has an important clinical value for planning cancer radiotherapy target volume. Purpose: This study aimed to develop an improved, automated production of18F-FMISO and to perform Micro-PET/CT imaging of tumor hypoxia. Methods: Based on the labeling precursor NITTP and a simple one-pot method, an upgraded Explora GN module together with Explora LC was adopted to run radiofluorination(NITTP(10 mg), MeCN(1.0 mL), 120oC,5.0 min), hydrolysis(HCl(1.0 mol/L,1.0 mL), 130oC, 8.0 min) and high performance liquid chromatography(HPLC) purification to produce18F-FMISO automatically. Moreover, Radio-HPLC and Radio-TLC were applied for the quality control, and Micro-PET/CT scanner for hypoxia imaging of SW1990 pancreatic tumor-bearing mice. Results: As results,18F-FMISO was obtained with the synthesis time for about 65 min, the radiochemical yield of(30 5.0)%(no decay corrected, n=20),the radiochemical purity of above 99%, the specific activity of(2.04 0.17)×1011Bq· mol–1, plus with the enhanced chemical purity. Moreover, MicroPET/CT imaging showed that18F-FMISO presented whole-body distribution in SW1990 tumor-bearing mice, and the optimized time point for tumor hypoxia imaging was 3 h post injection with the uptake ratios of tumor-to-muscle of 3.00 0.08. Conclusion: In sum, we developed an improved, automated production of18F-FMISO with high performance liquid chromatography purification, high radiochemical yield, high specific activity and high reliability, and also verified its MicroPET/CT imaging of tumor hypoxia for providing experimental reference data.